Ref.: BL-RE-092939Manufacturer ref.: EHTNFRSF14X10 10 x 96 tests
€4,815.00 excl. VAT
TNFRSF14 is a member of the TNF receptor superfamily. TNFRSF14 has been identified as a cellular mediator for the entry of the herpes simplex virus (HSV). It has been shown that binding of the glycoprotein D (gD) of the viral envelope...
Accession number
Q92956
Dose range
32.77 to 8.000 pg/ml
Sensitivity of the dosage
30 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
TNFRSF14 is a member of the TNF receptor superfamily. TNFRSF14 has been identified as a cellular mediator for the entry of the herpes simplex virus (HSV). It has been shown that binding of the glycoprotein D (gD) of the viral envelope...
TNFRSF14 is a member of the TNF receptor superfamily. TNFRSF14 has been identified as a cellular mediator for the entry of the herpes simplex virus (HSV). The binding of glycoprotein D (gD) from the HSV viral envelope to TNFRSF14 has been shown to be part of the virus entry mechanism. The cytoplasmic region of TNFRSF14 has been shown to be linked to several members of the TRAF family, who can act as mediators for signal transduction pathways that activate the immune response. The activation of the signal transduction pathway involving TNFRSF14 in T cells stimulates T cell proliferation and cytokine production, resulting in increased inflammation and tumour immunity at CTL mediation, suggesting that these proteins may be useful as potential targets for the control of cellular immune responses. Several variants of spliced transcription were described, but the full length nature was not determined for some of these variants of TNFRSF14.
Sensitivity
Sensitivity of the dosage: 30 pg/ml.
Measurement range
Dose range: 32.77 to 8.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.